{"id":55715,"date":"2026-01-28T20:54:36","date_gmt":"2026-01-28T12:54:36","guid":{"rendered":"https:\/\/flcube.com\/?p=55715"},"modified":"2026-01-28T20:54:37","modified_gmt":"2026-01-28T12:54:37","slug":"apeloa-partners-with-mindrank-on-ai-drug-development-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55715","title":{"rendered":"Apeloa Partners with MindRank on AI Drug Development Platform"},"content":{"rendered":"\n<p><strong>Apeloa Pharmaceutical Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/000739:SHE\">SHE: 000739<\/a>), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with <strong>MindRank Ltd.<\/strong>, an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-structure-amp-strategic-terms\">Partnership Structure &amp; Strategic Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>Apeloa Pharmaceutical Co., Ltd. (000739.SZ) \/ MindRank Ltd.<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>AI\u2011driven drug development collaboration<\/td><\/tr><tr><td><strong>Focus Area<\/strong><\/td><td>Chemical drug R&amp;D and compound synthesis optimization<\/td><\/tr><tr><td><strong>Technology Platform<\/strong><\/td><td>MindRank\u2019s self\u2011developed MindSyner AI synthesis platform<\/td><\/tr><tr><td><strong>Key Capabilities<\/strong><\/td><td>AI\u2011driven route design, process parameter optimization, risk warning<\/td><\/tr><tr><td><strong>Scope<\/strong><\/td><td>End\u2011to\u2011end workflow from molecular design to mass production<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Deep integration of AI with CDMO operations for improved R&amp;D efficiency<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile-amp-innovation\">Technology Profile &amp; Innovation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>MindSyner AI Synthesis Platform:<\/strong> Provides data\u2011driven route design for chemical synthesis, optimizing process parameters and providing early risk warnings<\/li>\n\n\n\n<li><strong>Integration with CDMO:<\/strong> Platform accelerates Apeloa\u2019s project pipeline by bridging molecular design, process implementation, and scalable manufacturing<\/li>\n\n\n\n<li><strong>Competitive Edge:<\/strong> AI\u2011enabled synthesis reduces trial\u2011and\u2011error iterations, shortening development timelines and lowering costs for both innovator and generic drug projects<\/li>\n\n\n\n<li><strong>IP Protection:<\/strong> Collaboration leverages robust intellectual property protection and confidentiality management systems to safeguard proprietary data<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-commercial-outlook\">Market Impact &amp; Commercial Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global AI Drug Development Market:<\/strong> Valued at <strong>$1.5\u202fbillion<\/strong> in 2025, projected to reach <strong>$6\u202fbillion<\/strong> by 2030 (CAGR\u202f\u2248\u202f30%)<\/li>\n\n\n\n<li><strong>China CDMO Market:<\/strong> Estimated <strong>\u00a5150\u202fbillion<\/strong> : (~US$21\u202fbillion) in 2025, with AI integration emerging as key competitive differentiator<\/li>\n\n\n\n<li><strong>Revenue Potential:<\/strong> Analysts estimate AI\u2011enabled process optimization could improve Apeloa\u2019s project throughput by <strong>20\u201330%<\/strong>, potentially adding <strong>\u00a51\u20132\u202fbillion<\/strong> : in incremental revenue by 2028<\/li>\n\n\n\n<li><strong>Strategic Validation:<\/strong> Partnership positions Apeloa as an early mover in AI\u2011driven CDMO services, attracting biotech clients seeking efficiency gains<\/li>\n\n\n\n<li><strong>Competitive Landscape:<\/strong> Rival Chinese CDMOs (WuXi STA, Asymchem) are exploring similar AI partnerships; Apeloa\u2011MindRank collaboration creates immediate capability moat<\/li>\n\n\n\n<li><strong>Next Steps:<\/strong> Pilot project initiation expected <strong>Q1\u202f2026<\/strong>; platform rollout across Apeloa\u2019s R&amp;D portfolio targeted for <strong>H2\u202f2026<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding technology integration timelines, revenue projections, and market adoption of AI\u2011driven CDMO services. Actual results may differ due to technology implementation risks, competitive dynamics, and regulatory changes affecting AI applications in drug manufacturing.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced&#8230;<\/p>\n","protected":false},"author":1,"featured_media":55718,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[170,19,765,897],"class_list":["post-55715","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-apeloa-pharmaceutical","tag-cro-cmo-cdmo","tag-mindrank","tag-she-000739"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Apeloa Partners with MindRank on AI Drug Development Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55715\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apeloa Partners with MindRank on AI Drug Development Platform\" \/>\n<meta property=\"og:description\" content=\"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55715\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-28T12:54:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-28T12:54:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Apeloa Partners with MindRank on AI Drug Development Platform\",\"datePublished\":\"2026-01-28T12:54:36+00:00\",\"dateModified\":\"2026-01-28T12:54:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715\"},\"wordCount\":386,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2801-1.webp\",\"keywords\":[\"Apeloa Pharmaceutical\",\"CRO \\\/ CMO \\\/ CDMO\",\"MindRank\",\"SHE: 000739\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55715#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55715\",\"name\":\"Apeloa Partners with MindRank on AI Drug Development Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2801-1.webp\",\"datePublished\":\"2026-01-28T12:54:36+00:00\",\"dateModified\":\"2026-01-28T12:54:37+00:00\",\"description\":\"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55715\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2801-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2801-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Apeloa Partners with MindRank on AI Drug Development Platform\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55715#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apeloa Partners with MindRank on AI Drug Development Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Apeloa Partners with MindRank on AI Drug Development Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55715","og_locale":"en_US","og_type":"article","og_title":"Apeloa Partners with MindRank on AI Drug Development Platform","og_description":"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.","og_url":"https:\/\/flcube.com\/?p=55715","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-28T12:54:36+00:00","article_modified_time":"2026-01-28T12:54:37+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55715#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55715"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Apeloa Partners with MindRank on AI Drug Development Platform","datePublished":"2026-01-28T12:54:36+00:00","dateModified":"2026-01-28T12:54:37+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55715"},"wordCount":386,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=55715#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","keywords":["Apeloa Pharmaceutical","CRO \/ CMO \/ CDMO","MindRank","SHE: 000739"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55715#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55715","url":"https:\/\/flcube.com\/?p=55715","name":"Apeloa Partners with MindRank on AI Drug Development Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=55715#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=55715#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","datePublished":"2026-01-28T12:54:36+00:00","dateModified":"2026-01-28T12:54:37+00:00","description":"Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China\u2011based contract development and manufacturing organization (CDMO), announced a collaboration agreement with MindRank Ltd., an artificial intelligence (AI)\u2011enabled drug developer, to integrate AI into chemical drug research and development. The partnership aims to enhance efficiency, cost\u2011effectiveness, and accuracy across the compound synthesis workflow.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55715#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55715"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=55715#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","width":1080,"height":608,"caption":"Apeloa Partners with MindRank on AI Drug Development Platform"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55715#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Apeloa Partners with MindRank on AI Drug Development Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2801-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55715"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55715\/revisions"}],"predecessor-version":[{"id":55719,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55715\/revisions\/55719"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/55718"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}